The Market Introduction of Biogen's Aduhelm Against Alzheimer's Finished After One Year: The Story
Aduhelm, a medication to treat mild stages of Alzheimer's disease, was launched by Biogen in June 2021. The approval was highly...
top of page
Search
Titus Kaletta
Oct 24, 20214 min read
Market Approval Is NOT Market Introduction!
Die Reduktion einer Markteinführung auf Zulassungsthemen führt regelmäßig zum Misserfolg.
6 views0 comments
Titus Kaletta
Aug 10, 20214 min read
Go-To-Market Strategy for Health Tech Newcomers
Young companies regularly discover that their product, their innovation does not generate the sales they had hoped for. The sobering...
15 views0 comments
bottom of page